Baudax Bio Inc (BXRX) stock has fallen -93.15% over the last 12 months, and the average rating from Wall Street analysts is a Hold. InvestorsObserver’s proprietary ranking system, gives BXRX stock a score of 3 out of a possible 100.
That rank is primarily influenced by a short-term technical score of 3. BXRX's rank also includes a long-term technical score of 6. BXRX has an Overall Score of 3. Find out what this means to you and get the rest of the rankings on BXRX!